Walter E P Beyer

Summary

Country: The Netherlands

Publications

  1. ncbi Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis
    Walter E P Beyer
    National Influenza Centre, Department of Virology, Erasmus Medical Centre, P O Box 1738, NL 3000 DR Rotterdam, The Netherlands
    Vaccine 24:6602-4. 2006
  2. ncbi Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain
    Emmie de Wit
    Department of Virology, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
    J Virol 79:12401-7. 2005
  3. ncbi Mortality benefits of influenza vaccination in elderly people
    Carel Thijs
    Lancet Infect Dis 8:460-1; author reply 463-5. 2008

Collaborators

  • Guus F Rimmelzwaan
  • Carel Thijs
  • Emmie de Wit
  • Phile M E Govaert
  • Marc J W Sprenger
  • Geert-Jan Dinant
  • Monique I J Spronken
  • Chantal Baas
  • Theo M Bestebroer
  • Vincent J Munster
  • Ron A M Fouchier
  • Albert D M E Osterhaus

Detail Information

Publications3

  1. ncbi Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis
    Walter E P Beyer
    National Influenza Centre, Department of Virology, Erasmus Medical Centre, P O Box 1738, NL 3000 DR Rotterdam, The Netherlands
    Vaccine 24:6602-4. 2006
    ..Such findings call for a cautious interpretation of combined vaccine effectiveness estimates. Internationally agreed case and observation period definitions would be desirable to facilitate future meta-analyses...
  2. ncbi Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain
    Emmie de Wit
    Department of Virology, Erasmus Medical Center, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
    J Virol 79:12401-7. 2005
    ..The data presented suggest that vaccine candidates based on low-pathogenicity avian influenza A viruses, which can be prepared ahead of pandemic threats, can be efficacious if an effective adjuvant is used...
  3. ncbi Mortality benefits of influenza vaccination in elderly people
    Carel Thijs
    Lancet Infect Dis 8:460-1; author reply 463-5. 2008